Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check2 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the study record.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision upgraded from v3.6.3 to v3.6.4, signaling a new page revision. This indicates a small update to the page's underlying documentation or configuration rather than a user-facing content change.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new version of the page likely containing minor updates or fixes rather than substantive content changes.SummaryDifference0.0%

- Check46 days agoChange Detected- The page revision was updated from v3.6.0 to v3.6.2, indicating a newer patch level. - The update appears to be a minor maintenance change with no substantive content changes.SummaryDifference0.0%

- Check60 days agoChange DetectedThe update adds new navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the 'Intervention/Treatment' header formatting, along with a new page revision label (v3.6.0); it also includes a recruitment status change indicating no further enrollment.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This appears to be a metadata/version update and does not modify the study content or visible data.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.